News
Q2 2025 MANAGEMENT VIEW * CEO Jurgi Camblong reported, "revenue growth continued to reaccelerate and cash burn decreased notably," highlighting that t... To keep reading, please log in to your account ...
Sanofi finalise l’acquisition de Vigil Neuroscience, Inc. Paris, le 6 août 2025. Sanofi annonce la finalisation de l’acquisition de Vigil Neuroscience, Inc. (« Vigil »). Cette acquisition renforce le ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback